High-dose thymidine infusions in patients with leukemia and lymphoma.
D000293:Adolescent; D000328:Adult; D001853:Bone Marrow / Q000187:drug effects; D002648:Child; D006412:Hematopoietic Stem Cells / Q000201:enzymology; D006529:Hepatomegaly / Q000188:drug therapy; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000097:blood; D007958:Leukocyte Count; D008223:Lymphoma / Q000188:drug therapy*; D008875:Middle Aged; D013163:Splenomegaly / Q000188:drug therapy; D013601:T-Lymphocytes; D013936:Thymidine / Q000097:blood / Q000627:therapeutic use*; D013937:Thymidine Kinase / Q000378:metabolism; D013939:Thymidine Phosphorylase / Q000378:metabolism; D013941:Thymine / Q000097:blood
D013939:Thymidine Phosphorylase; D013937:Thymidine Kinase; D013941:Thymine; D013936:Thymidine